Franklin Biotechnology Discovery Fund A(acc)USD

Register to Unlock Ratings
Performance History31/03/2025
Growth of 1,000 (GBP) Advanced Graph
Franklin Biotechnology Discovery Fund A(acc)USD
Fund-16.6-1.510.74.5-7.4
+/-Cat-7.66.412.07.4-1.1
+/-B’mrk-16.9-3.93.411.1-3.9
 
Key Stats
NAV
23/04/2025
 USD 36.25
Day Change 1.53%
Morningstar Category™ Sector Equity Biotechnology
ISIN LU0109394709
Fund Size (Mil)
31/03/2025
 USD 1281.59
Share Class Size (Mil)
22/04/2025
 USD 921.68
Max Initial Charge 5.75%
Ongoing Charge
12/02/2025
  1.79%
Morningstar Research
Analyst Report07/10/2024
David Kathman, Senior Analyst
Morningstar, Inc

Franklin Biotechnology Discovery is overseen by experienced managers, but limited resources and an undifferentiated process earn the fund a Morningstar Analyst Rating of Neutral.This strategy’s compact team is composed of three managers who have...

Click here to read this analyst report on the underlying fund.
Morningstar Pillars
People23
Parent23
Process23
Performance
Price
Investment Objective: Franklin Biotechnology Discovery Fund A(acc)USD
The Fund’s investment objective is capital appreciation. The Fund invests principally in equity securities of biotechnology companies and discovery research firms (including small to mid-sized companies) located in the US and other countries, and to a lesser extent in debt securities of any type of issuers worldwide.
Returns
Trailing Returns (GBP)23/04/2025
YTD-12.86
3 Years Annualised2.29
5 Years Annualised-0.47
10 Years Annualised0.86
12 Month Yield 0.00
Management
Manager Name
Start Date
Evan McCulloch
01/11/2000
Akiva Felt
31/01/2020
Inception Date
03/04/2000
Advertisement
Category Benchmark
Fund BenchmarkMorningstar Benchmark
NASDAQ Biotechnology TR USDMorningstar Gbl Biotechnology NR USD
Target Market
Role In Portfolio
Standalone / CoreNot Specific
ComponentNot Specific
OtherNot Specific
Primary Objective
PreservationNot Specific
GrowthYes
IncomeNot Specific
HedgingNot Specific
OtherNot Specific
Portfolio Profile for  Franklin Biotechnology Discovery Fund A(acc)USD31/03/2025
Morningstar Style Box®
Equity Style
Asset Allocation
  % Long% Short% Net Assets
Stock95.770.0095.77
Bond0.000.000.00
Property0.000.000.00
Cash4.230.004.23
Other0.000.000.00
Top 5 Regions%
United States81.20
Europe - ex Euro5.32
Eurozone5.17
Asia - Emerging3.91
United Kingdom3.58
Top 5 Sectors%
Healthcare100.00
Top 5 HoldingsSector%
Amgen IncHealthcareHealthcare7.80
Gilead Sciences IncHealthcareHealthcare7.69
Vertex Pharmaceuticals IncHealthcareHealthcare7.56
Regeneron Pharmaceuticals IncHealthcareHealthcare5.34
Ascendis Pharma AS ADRHealthcareHealthcare4.35
Franklin Biotechnology Discovery Fund A(acc)USD

Related

In order to provide consistency across the report data provided by different Asset Managers, the calculated data points presented are generated using Morningstar’s proprietary calculation methodology which is set out in more detail at(https://www.morningstar.com/research/signature)
© Copyright 2025 Morningstar, Inc. All rights reserved.

Terms of Use        Privacy Policy        Modern Slavery Statement        Cookie Settings        Disclosures